[1] |
McManus DP, Dunne DW, Sacko M, et al. Schistosomiasis[J]. Nat Rev Dis Primers, 2018, 4: 13.
doi: 10.1038/s41572-018-0013-8
pmid: 30093684
|
[2] |
Lin JJ. Endemic status and control of animal schistosomiasis in China[J]. Chin J Schisto Control, 2019, 31(1): 40-46. (in Chinese)
|
|
(林矫矫. 我国家畜血吸虫病流行情况及防控进展[J]. 中国血吸虫病防治杂志, 2019, 31(1): 40-46.)
|
[3] |
Feng JX, Gong YF, Luo ZW, et al. Scientific basis of strategies for schistosomiasis control and prospect of the 14th Five-Year Plan in China[J]. Chin J Parasitol Parasit Dis, 2022, 40(4): 428-435. (in Chinese)
|
|
(冯家鑫, 公衍峰, 罗卓韦, 等. 我国血吸虫病防治策略的科学基础与“十四五”展望[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(4): 428-435.)
|
[4] |
Lu S, Wang SX, Grimes-Serrano JM. Current progress of DNA vaccine studies in humans[J]. Expert Rev Vaccines, 2008, 7(2): 175-191.
doi: 10.1586/14760584.7.2.175
pmid: 18324888
|
[5] |
Cai Y, Rodriguez S, Hebel H. DNA vaccine manufacture: scale and quality[J]. Expert Rev Vaccines, 2009, 8(9): 1277-1291.
doi: 10.1586/erv.09.84
pmid: 19722898
|
[6] |
Ledwith BJ, Manam S, Troilo PJ, et al. Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice[J]. Intervirology, 2000, 43(4/5/6): 258-272.
doi: 10.1159/000053993
|
[7] |
Li MY, Wang ZN, Xie CY, et al. Advances in mRNA vaccines[J]. Int Rev Cell Mol Biol, 2022, 372: 295-316.
doi: 10.1016/bs.ircmb.2022.04.011
pmid: 36064266
|
[8] |
De Beuckelaer A, Grooten J, De Koker S. Type I interferons modulate CD8+ T cell immunity to mRNA vaccines[J]. Trends Mol Med, 2017, 23(3): 216-226.
doi: S1471-4914(17)30006-0
pmid: 28185789
|
[9] |
McManus DP, Loukas A. Current status of vaccines for schistosomiasis[J]. Clin Microbiol Rev, 2008, 21(1): 225-242.
doi: 10.1128/CMR.00046-07
pmid: 18202444
|
[10] |
Tang CL, Pan Q, Dai WQ, et al. Administration of anti-CTLA-4 monoclonal antibody augments protective immunity induced by Schistosoma japonicum glutathione-S-transferase[J]. Parasite Immunol, 2019, 41(8): e12657.
doi: 10.1111/pim.2019.41.issue-8
|
[11] |
Arnon R, Tarrab-Hazdai R, Steward M. A mimotope peptide-based vaccine against Schistosoma mansoni: synthesis and characterization[J]. Immunology, 2000, 101(4): 555-562.
pmid: 11122460
|
[12] |
Chen B, Zhang GL, Zhang GH. Research progress on clinical trials of schistosomiasis vaccine candidates[J]. Chin J Parasitol Parasit Dis, 2022, 40(4): 511-515. (in Chinese)
|
|
(陈兵, 张国莉, 张高红. 血吸虫病候选疫苗临床研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(4): 511-515.)
|
[13] |
Pourseif MM, Masoudi-Sobhanzadeh Y, Azari E, et al. Self-amplifying mRNA vaccines: mode of action, design, development and optimization[J]. Drug Discov Today, 2022, 27(11): 103341.
doi: 10.1016/j.drudis.2022.103341
|
[14] |
Li L, Petrovsky N. Molecular mechanisms for enhanced DNA vaccine immunogenicity[J]. Expert Rev Vaccines, 2016, 15(3): 313-329.
doi: 10.1586/14760584.2016.1124762
pmid: 26707950
|
[15] |
Tan X, Xiao CL, Xiao F, et al. Immunoprotective effect of DNA vaccine against Schistosoma japonicum surface membrane protein SjOST48[J]. Chin J Parasitol Parasit Dis, 2021, 37(7): 791-795. (in Chinese)
|
|
(谭潇, 肖楚丽, 肖非, 等. 日本血吸虫表膜蛋白SjOST48 DNA疫苗的免疫保护作用研究[J]. 中国免疫学杂志, 2021, 37(7): 791-795.)
|
[16] |
Wadman M. The overlooked superpower of mRNA vaccines[J]. Science, 2021, 373(6554): 479.
doi: 10.1126/science.373.6554.479
pmid: 34326217
|
[17] |
Pardi N, Carreño JM, O’dell G, et al. Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses[J]. Nat Commun, 2022, 13(1): 4677.
doi: 10.1038/s41467-022-32149-8
pmid: 35945226
|
[18] |
Rutitzky LI, Stadecker MJ. Exacerbated egg-induced immunopathology in murine Schistosoma mansoni infection is primarily mediated by IL-17 and restrained by IFN-γ[J]. Eur J Immunol, 2011, 41(9): 2677-2687.
doi: 10.1002/eji.201041327
pmid: 21660933
|
[19] |
VanBlargan LA, Himansu S, Foreman BM, et al. An mRNA vaccine protects mice against multiple tick-transmitted flavivirus infections[J]. Cell Rep, 2018, 25(12): 3382-3392.e3.
doi: S2211-1247(18)31873-4
pmid: 30566864
|
[20] |
Pardi N, Hogan MJ, Pelc RS, et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination[J]. Nature, 2017, 543(7644): 248-251.
doi: 10.1038/nature21428
|